• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tuberculosis: where are we?

作者信息

Mello Fernanda Carvalho de Queiroz, Silva Denise Rossato, Dalcolmo Margareth Pretti

机构信息

Instituto de Doenças do Tórax, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

出版信息

J Bras Pneumol. 2018 Apr;44(2):82. doi: 10.1590/s1806-37562017000000450.

DOI:10.1590/s1806-37562017000000450
PMID:29791544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6044658/
Abstract
摘要

相似文献

1
Tuberculosis: where are we?结核病：我们目前处于什么状况？
J Bras Pneumol. 2018 Apr;44(2):82. doi: 10.1590/s1806-37562017000000450.
2
Tuberculosis series.结核病系列
J Bras Pneumol. 2018 Apr;44(2):71-72. doi: 10.1590/s1806-37562018000020001.
3
Nearly 70% of tuberculosis cases remain undetected.
Lancet Infect Dis. 2002 Jun;2(6):319. doi: 10.1016/s1473-3099(02)00301-8.
4
Assessing the impact of new diagnostics on tuberculosis control.评估新型诊断方法对结核病控制的影响。
Int J Tuberc Lung Dis. 2010 Dec;14(12):1506-7.
5
Editorial: W.H.O. and tuberculosis.
Lancet. 1974 Nov 30;2(7892):1298-9.
6
Tuberculosis serodiagnostics: Ban and after.
Int J Mycobacteriol. 2017 Oct-Dec;6(4):323-325. doi: 10.4103/ijmy.ijmy_144_17.
7
Tuberculin test and tuberculosis control in a low-prevalence country today.当今低发病率国家的结核菌素试验与结核病控制
Monaldi Arch Chest Dis. 1997 Aug;52(4):323.
8
[New stage of tuberculosis control in Russia].
Probl Tuberk. 2002(6):4.
9
Back to the future: Rethinking global control of tuberculosis.
Sci Transl Med. 2016 Mar 9;8(329):329ps7. doi: 10.1126/scitranslmed.aaf2944.
10
Control of tuberculosis transmission in health care settings. A joint statement of the WHO Tuberculosis Programme and the International Union Against Tuberculosis and Lung Disease (IUATLD).医疗机构中结核病传播的控制。世界卫生组织结核病规划和国际防痨和肺部疾病联盟（IUATLD）联合声明。
Wkly Epidemiol Rec. 1993 Dec 10;68(50):369-71.

引用本文的文献

1
Introducing the NUATEI Consortium: A Mexican Research Program for the Identification of Natural and Synthetic Antimicrobial Compounds for Prevalent Infectious Diseases.介绍NUATEI联盟：一项墨西哥研究计划，旨在鉴定用于常见传染病的天然和合成抗菌化合物。
Pharmaceuticals (Basel). 2024 Jul 18;17(7):957. doi: 10.3390/ph17070957.
2
Epidemiology of tuberculosis in Saudi Arabia following the implementation of end tuberculosis strategy: Analysis of the surveillance data 2015-2019.沙特阿拉伯实施终结结核病策略后结核病的流行病学：2015-2019 年监测数据分析。
Saudi Med J. 2024 Jan;45(1):60-68. doi: 10.15537/smj.2024.45.1.20230424.
3
Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis.抗结核药物性肝损伤的发病率及时间趋势：一项系统评价和荟萃分析
J Trop Med. 2022 Oct 4;2022:8266878. doi: 10.1155/2022/8266878. eCollection 2022.
4
Mechanistic insights into the antimycobacterial action of unani formulation, Qurs Sartan Kafoori.尤那尼配方药物库尔思·萨尔坦·卡富里抗分枝杆菌作用的机制研究
J Tradit Complement Med. 2021 Jul 30;12(2):162-171. doi: 10.1016/j.jtcme.2021.07.009. eCollection 2022 Mar.
5
Microencapsulated Isoniazid-Loaded Metal-Organic Frameworks for Pulmonary Administration of Antituberculosis Drugs.载异烟肼的金属有机框架的微囊化用于抗结核药物的肺部给药。
Molecules. 2021 Oct 23;26(21):6408. doi: 10.3390/molecules26216408.
6
Molecular Analysis of Streptomycin Resistance Genes in Clinical Strains of and Biocomputational Analysis of the GidB L101F Variant.临床菌株中链霉素抗性基因的分子分析及GidB L101F变体的生物计算分析。
Antibiotics (Basel). 2021 Jul 2;10(7):807. doi: 10.3390/antibiotics10070807.
7
Occult pulmonary arterial hypertension in patients with previous pulmonary tuberculosis.既往肺结核患者的隐匿性肺动脉高压
Afr J Thorac Crit Care Med. 2020 Dec 1;26(4). doi: 10.7196/AJTCCM.2020.v26i4.110. eCollection 2020.
8
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis.可吸入莫西沙星微球的肺部靶向给药用于结核病的有效治疗
Pharmaceutics. 2021 Jan 8;13(1):79. doi: 10.3390/pharmaceutics13010079.
9
Trends in tuberculosis mortality in Brazil (1990-2015): joinpoint analysis.巴西结核病死亡率趋势（1990 - 2015年）：连接点分析
J Bras Pneumol. 2019 Apr 25;45(2):e20180393. doi: 10.1590/1806-3713/e20180393.
10
In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations.通过分层虚拟筛选和分子动力学模拟从天然来源中鉴定新型抗结核分子的计算机模拟研究
Pharmaceuticals (Basel). 2019 Mar 12;12(1):36. doi: 10.3390/ph12010036.

本文引用的文献

1
Tuberculosis treatment.结核病治疗
J Bras Pneumol. 2017 Nov-Dec;43(6):472-486. doi: 10.1590/S1806-37562016000000388.
2
Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey.活动性结核病新型诊断检测方法的当前使用情况及可接受性：一项全球调查。
J Bras Pneumol. 2017 Sep-Oct;43(5):380-392. doi: 10.1590/S1806-37562017000000219.
3
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.美国胸科学会/传染病学会/疾病控制与预防中心临床实践指南：成人和儿童结核病诊断。
Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.
4
Diagnosis of tuberculosis and drug resistance: what can new tools bring us?结核病与耐药性诊断：新工具能为我们带来什么？
Int J Tuberc Lung Dis. 2012 Jul;16(7):860-70. doi: 10.5588/ijtld.12.0180.